Diseño y validación de un sistema inmunoenzimático elisa para cuantificar lipoproteína a en suero humano

Jevey González, Aidelian; Pedrosa Amado, Andrés; Nápoles Vega, Ángel; ernández González, Silvia; Ramírez Zayas, Silvia.
Arch. méd. Camaguey ; 9(1)ene.-feb. 2005. tab, graf
Artículo en Español | LILACS | ID: lil-461112

Documentos relacionados

  1. Enabling structure-based drug discovery utilizing predicted models.
  2. A general chemical principle for creating closure-stabilizing integrin inhibitors.
  3. Bacterial Lipoprotein Biosynthetic Pathway as a Potential Target for Structure-based Design of Antibacterial Agents.
  4. Explore drug-like space with deep generative models.
  5. ADMET-PrInt: Evaluation of ADMET Properties: Prediction and Interpretation.
  6. Design, synthesis and immunological evaluation of 1,2,3-triazole-tethered carbohydrate-Pam3Cys conjugates as TLR2 agonists.
  7. Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models.
  8. MGCVAE: Multi-Objective Inverse Design via Molecular Graph Conditional Variational Autoencoder.
  9. Computer-designed repurposing of chemical wastes into drugs.
  10. On the Value of Using 3D Shape and Electrostatic Similarities in Deep Generative Methods.